245
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Drugs on the Internet, Part V: Absinthe, Return of the Emerald Mask

Pages 506-512 | Published online: 08 Apr 2013

REFERENCES

  • alah0007. (2008). What causes the absinthe effect? Retrieved December 14, 2012, from http://blog.lib.umn.edu/alah0007/ causesabsintheeffect/.
  • Arnold, W. N. (1989). Absinthe. Scientific American, 260(6), 112–117.
  • Ashcraft, B. (2009). The mystery of the green menace. Wired, 13(11), 1–3. Retrieved December 14, 2012 from http://www. wired.com/wired/archive/13.11/absinthe_pr.html.
  • Atkins, T. (2005, March 23). Swiss face sobering future after legalizing absinthe. U-T San Diego. Retrieved December 14, 2012, from http://legacy.utsandiego.com/news/features/20050323-0500-life-absinthe.html.
  • Baker, P. (2001). The book of absinthe: A cultural history. New York: Grove Books.
  • Corelli, M. (1890). Wormwood: A drama in Paris (3 vol.). London: Richard Bentley and Son.
  • Conrad, III, B. (1988). Absinthe: History in a bottle. San Francisco: Chronicle Books.
  • Crowley, A. (1918). Absinthe: The green goddess. The International, XII(2), 47–51. Retrieved from http://www.oxygenee. com/Crowley-Green-Goddess.pdf.
  • Erowid. (2010). Absinthe vault. Retrieved December 25, 2012, from www.erowid.org/chemicals/absinthe/absinthe.shtml.
  • Hold, K. M. (2000). α-Thujone (the active component of absinthe): γ-Aminobutyric acid type A receptor modulation and metabolic detoxification. Proceedings of the National Academy of Sciences, 97, 3826–3831.
  • Huisman, M., Brug, J., & Mackenbach, J. (2007). Absinthe—Is its history relevant for current public health? International Journal of Epidemiology, 36, 738–744.
  • Lachenmeier, D. W., Nathan-Maister, D, Breaux, T. A., Sohnius, E.-M., Schoeberl, K., & Kuball, T. (2008). Chemical composition of vintage preban absinthe with special reference to thujone, fenchone, pinocamphone, methanol, copper, and antimony concentrations. Journal of Agricultural and Food Chemistry, 56, 3073–3081.
  • Lachenmeier, D. W., Nathan-Maister, D., Breaux, T. A., & Kuballa, T. (2009). Long-term stability of thujone, fenchone, and pinocamphone in vintage preban absinthe. Journal of Agricultural and Food Chemistry, 57, 2782–2785.
  • Lancet. (1868). Absinthe. Lancet, 9, 600–601.
  • Luaute, J. P. (2007). Absinthism: The fault of Doctor Magnan. The Evolution of Psychiatry, 72, 515–530.
  • Luaute, J. P., Saladini, O., & Benyaya, J. (2005). Neuropsychiatric toxicity of absinthe: History, current data. Annales Medico-Psychologiques (Paris), 163, 497–501.
  • Meschler, J. P., & Howlett, A. C. (1999). Thujone exhibits low affinity for cannabinoid receptors but fails to evoke cannabimimetic responses. Pharmacology Biochemistry and Behavior, 62, 473–480.
  • Montagne, M. (2008). Drugs on the Internet. I: Introduction and web sites on psychedelic drugs. Substance Use & Misuse, 43, 17–25.
  • Morgan, M., & Montagne, M. (2013). Drugs on the Internet, Part III: Tobacco and smoking on the web. Substance Use & Misuse, 48, 82–88.
  • Padosch, S. A., Lachenmeier, D. W., & Kroner, L. U. (2006). Absinthism: A fictitious 19th century syndrome with present impact. Substance Abuse Treatment, Prevention, and Policy, 1, 1–14.
  • Patocka, J., & Plucar, B. (2003). Pharmacology and toxicology of absinthe. Journal of Applied Biomedicine, 1, 199–205.
  • Rimbaud, A. (2002). From Absinthe to Abyssinia: Selected miscellaneous, obscure, and previously untranslated works of Jean-Nicolas-Arthur Rimbaud. M. Spitzer (Trans.). Berkeley, CA: Creative Arts Book Co.
  • Rogers, E. M. (1995). The diffusion of innovation. New York: Free Press.
  • Skrzycki, C. (October 16, 2007). A notorious spirit finds its way back to bars. Washington Post. p. D2.
  • Vogt, D. D., & Montagne, M. (1982). Absinthe: Behind the emerald mask. International Journal of the Addictions, 17, 1015–1029.
  • Wells, P. (December 5, 2007). A liquor of legend makes a comeback. The New York Times. p. F1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.